XML 16 R7.htm IDEA: XBRL DOCUMENT v3.23.2
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2023
Mar. 31, 2023
Jun. 30, 2022
Mar. 31, 2022
Jun. 30, 2023
Jun. 30, 2022
Dec. 31, 2022
Cash flows from operating activities:              
Net income $ 150,064 $ 253,993 $ 68,458 $ 8,792 $ 404,057 $ 77,250  
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities              
Depreciation and amortization         122,147 113,957  
Amortization of deferred financing fees         1,110 1,076  
Loss (gain) on disposal of assets         9,542 (1,689)  
Loss on contingent consideration liability           (2,500)  
Payments for contingent consideration         (37,324)    
Gain on financial instrument and derivatives, net         (1,485) (6,302)  
Stock-based compensation         19,831 16,995  
Gain on insurance proceeds recognized in other income         (1,133) 0  
Deferred income tax benefit (5,500)       (112,926) 0  
Changes in operating assets and liabilities:              
Increase in trade and other accounts receivable, net         (46,520) (154,898)  
Increase in inventories         (13,745) (19,780)  
Decrease in prepaid and other current assets         1,659 18,559  
Decrease in other assets         5,813 7,113  
Increase in accounts payable         105,123 51,940  
(Decrease) increase in accrued expenses         (50,532) 69,998  
Decrease in customer contract liabilities         0 (2,192)  
Decrease in other liabilities         (6,410) (23,027)  
Net cash provided by operating activities         399,207 146,500  
Cash flows from investing activities:              
Purchase of property and equipment         (181,427) (81,290)  
Advances of deposit on equipment         (13,965) (3,416)  
Implementation of software         (5,349) (1,991)  
Proceeds from disposal of assets         5,280 9,223  
Assets and business acquisition         0 482  
Proceeds from insurance recoveries         104 20  
Net cash used in investing activities         (195,357) (76,972)  
Cash flows from financing activities:              
Payments on the term loan facility and asset based revolver         (7,638) (7,259)  
Payments on finance leases         (14,535) (6,621)  
Payment of debt issuance costs         0 (110)  
Shares repurchased and retired related to share repurchase program         (72,849) 0  
Payments for financing liabilities         (3,473) (3,996)  
Payments for contingent consideration         (3,081) 0  
Shares repurchased and retired related to stock-based compensation         (10,262) (4,354)  
Net cash used in financing activities         (111,838) (22,340)  
Non-cash effect of foreign translation adjustments         (322) 253  
Net increase in cash, cash equivalents and restricted cash         91,690 47,441  
Cash and cash equivalents, beginning   $ 218,476   $ 110,695 218,476 110,695 $ 110,695
Cash and cash equivalents, ending $ 310,166   $ 158,136   310,166 158,136 $ 218,476
Supplemental disclosure of cash flow information cash paid during the period for:              
Interest expense, net         12,270 13,366  
Income taxes         14,114 710  
Non-cash investing and financing activities:              
Change in accrued capital expenditures         (39,937) (17,318)  
Non-cash additions to finance right-of-use assets         56,923 6,222  
Non-cash additions to finance lease liabilities, including current maturities         (57,117) (6,020)  
Non-cash additions to operating right-of-use assets         16,032 2,886  
Non-cash additions to operating lease liabilities, including current maturities         $ (14,401) $ (2,848)